HIDRAdisk: an innovative visual tool to assess the burden of hidradenitis suppurativa (original) (raw)

Hidradenitis suppurativa: Basic considerations for its approach: A narrative review

Felipe Anduquia Garay

Annals of Medicine & Surgery, 2021

View PDFchevron_right

Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study

Alexa Kimball

American Journal of Clinical Dermatology, 2023

View PDFchevron_right

Clinical and demographic features of hidradenitis suppurativa: a multicentre study of 1221 patients with an analysis of risk factors associated with disease severity

Müge Ozden

Clinical and Experimental Dermatology, 2021

View PDFchevron_right

Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data

Alexa Kimball

Dermatology and therapy, 2022

View PDFchevron_right

What causes hidradenitis suppurativa?

Jan Lapins

Experimental Dermatology, 2008

View PDFchevron_right

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa

Marco Ardigò

Journal of the European Academy of Dermatology and Venereology, 2019

View PDFchevron_right

Factors Associated With Point-of-Care Treatment Decisions for Hidradenitis Suppurativa

Aaron Legler

JAMA Dermatology, 2016

View PDFchevron_right

Online communications among hidradenitis suppurativa patients reflect community needs

Alexa Kimball

Journal of The American Academy of Dermatology, 2019

View PDFchevron_right

A narrative review of the definition of ‘flare’ in hidradenitis suppurativa

Veronique Del Marmol

British Journal of Dermatology, 2019

View PDFchevron_right

Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA)

Alexa Kimball

Experimental Dermatology, 2017

View PDFchevron_right

Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017

Jerry Tan

Experimental Dermatology, 2018

View PDFchevron_right

Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota

David Wetter

Journal of Investigative Dermatology, 2013

View PDFchevron_right

Demographic and health care service utilization by 4417 patients with hidradenitis suppurativa

Nadav Pam

Journal of The American Academy of Dermatology, 2017

View PDFchevron_right

Hidradenitis Suppurativa [Clinical Image]

Jimmy Tam Huy Pham

The Journal of the American Osteopathic Association, 2014

View PDFchevron_right

Hidradenitis suppurativa has an enormous impact on patients’ lives

Irma Richardson

Journal of the American Academy of Dermatology

View PDFchevron_right

Specimen Collection for Translational Studies in Hidradenitis Suppurativa

Stephen Milner

Scientific Reports, 2019

View PDFchevron_right

Creation of a severity index for hidradenitis suppurativa that includes a validated quality‐of‐life measure: the HIDRAscore

Paolo Dapavo

Journal of the European Academy of Dermatology and Venereology, 2020

View PDFchevron_right

Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data

Veronique Del Marmol

Frontiers in Medicine

View PDFchevron_right

Diagnostic Delay in Hidradenitis Suppurativa is a Global Problem

Jan Lapins

The British journal of dermatology, 2015

View PDFchevron_right

Age and gender influence on HIDRAdisk outcomes in adalimumab‐treated hidradenitis suppurativa patients

Maria Fierro

Journal of the European Academy of Dermatology and Venereology

View PDFchevron_right

Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event

Christine Yannuzzi

British Journal of Dermatology, 2019

View PDFchevron_right

Recognizing and managing comorbidities and complications in hidradenitis suppurativa

Alan Menter

Seminars in cutaneous medicine and surgery, 2014

View PDFchevron_right

Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis

Allison Chen

View PDFchevron_right

What causes hidradenitis suppurativa ?—15 years after

John Frew

Experimental Dermatology, 2020

View PDFchevron_right

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial

Alexa Kimball

Dermatology and therapy, 2023

View PDFchevron_right

Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy

Nihal Kundakçi

Dermatologic Therapy, 2019

View PDFchevron_right

Practical Guidelines for Managing Patients With Hidradenitis Suppurativa: An Update

Ralph George

Journal of Cutaneous Medicine and Surgery

View PDFchevron_right

Clinical characteristics of low and high BMI Hidradenitis suppurativa patients

Ditte Saunte

2017

View PDFchevron_right

European registry for hidradenitis suppurativa: state of play

Hassane Njimi

Journal of the European Academy of Dermatology and Venereology

View PDFchevron_right

Validation of the Hidradenitis Suppurativa Investigator Global Assessment

Llenalia Garcia

JAMA Dermatology

View PDFchevron_right

Hidradenitis suppurativa: debilitating and challenging to treat

Shivam Kapila

2016

View PDFchevron_right

Race-Specific Prevalence of Hidradenitis Suppurativa

Monica Shah

Journal of Cutaneous Medicine and Surgery, 2020

View PDFchevron_right

Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies

Cedric Viallette, Sylvie Bastuji-garin

Journal of the American Academy of Dermatology, 2008

View PDFchevron_right

Hidradenitis suppurativa: A review of post-operative outcomes

Barbara Jemec

Journal of Plastic Reconstructive and Aesthetic Surgery, 2021

View PDFchevron_right

Epidemiology of hidradenitis suppurativa in Poland in relation to international data

Waldemar Placek

Dermatology Review, 2017

View PDFchevron_right